Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

October 31, 2005

Conditions
Carotid Artery Disease
Interventions
DEVICE

PROTÉGÉ® GPS™ and PROTÉGÉ® RX Carotid Stent Systems and Spider Embolic Protection Device

Carotid artery stenting with distal embolic protection.

Trial Locations (31)

14209

University of Buffalo Millard Fillmore Hospital, Buffalo

15212

Allegheny General Hospital, Pittsburgh

17043

Pinnacle Health at Harrisburg Hospital, Wormleysburg

17110

Holy Spirit Hospital, Harrisburg

19102

Hahnemann University Hospital, Philadelphia

20010

Washington Hospital Center, Washington D.C.

20912

Washington Adventist Hospital, Takoma Park

21218

Union Memorial Hospital, Baltimore

22908

University of Virginia, Charlottesville

27609

Duke University Medical Center, Raleigh

27610

Wake Heart Associates, Raleigh

29605

Greenville Hospital System, Greenville

37920

Baptist Heart Institute, Knoxville

43214

Riverside Methodist, Columbus

44111

Cleveland Clinic Foundation, Cleveland

46260

St. Vincent Hospital & Health Care Centers, Indianapolis

46290

The Heart Center of Indiana, Indianapolis

48073

William Beaumont Hospital, Royal Oak

48124

Oakwood Hospital, Dearborn

57108

Avera Heart Hospital of South Dakota, Sioux Falls

61637

St. Francis Medical Center, Peoria

63110

St. Louis University Medical Center, St Louis

66204

Kramer & Crouse Cardiology, Shawnee Mission

70360

Terrebonne General Hospital, Houma

70506

Southwest Medical Center, Lafayette

85205

Banner Baywood Heart Hospital, Mesa

92037

Scripps Memorial Hospital, La Jolla

92663

Hoag Memorial Hospital, Newport Beach

93901

Salinas Valley Memorial Healthcare System, Salinas

94040

El Camino Hospital, Mountain View

98122

Swedish Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT00619775 - Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial | Biotech Hunter | Biotech Hunter